Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline
Key facts
- Who runs it
- University of Wisconsin, Madison
- Where
- Madison, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 55 people, planned
- Started
- 13 Nov 2025
- Expected to end
- Jun 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Functional near-infrared spectroscopy (fNIRS)
- V1 stimulation electrodes
- Magnetic Resonance Imaging (MRI)
- MAGNUS scanner
- Record updated
- 4 November 2026
Who can take part
- Age
- 20 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Age 20-85 years
- Willing and able to undergo all procedures
- Free of any neurological (e.g., epilepsy, stroke, Parkinson's, brain tumors, moderate or severe traumatic brain injury), neuropsychiatric (e.g., schizophrenia, substance abuse, clinical depression), or developmental (e.g., autism, ADHD) or any other medical condition at the discretion of the PI and co-investigators
- Age 20-65
- Diagnosed with mild traumatic brain injury and be within 1-52 weeks post-injury
- Willing and able to undergo all procedures
Who cannot take part
- Known allergies to common electrode materials
- Known allergies to common electrode materials
- Candidates who have chronic infectious diseases (e.g. hepatitis, HIV, TB)
- Candidates diagnosed with small vessel disease, vascular associated dementia (e.g. VCID), or renal disease
- Candidates with neurological disorders other than those attributed to their primary diagnosis (e.g. MS, PD, ALS, AD or other dementia, uncontrolled pain)
- Candidates with a history of seizures (except those in the acute or post-acute phases and are controlled)
- Candidates currently on cardiovascular medications which, in the opinion of the investigators, would introduce a confounding factor to glymphatic system function (i.e. ACE-inhibitors, angiotensin receptor blockers, calcium channel blockers)
- Contraindication to MRI
- Contraindications for MRI
- Candidates retinopathies or neuropathies that, in the opinion of the investigators, would prevent them from being able to complete the study or would introduce a confounding factor to glymphatic system function
- Candidates who have had a penetrating injury, craniotomy (with the exception of a burr hole (trephination) for resolution of acute subdural hematoma), or refractory subdural hematoma
- Candidates who experienced a loss of consciousness greater than 24 hours as a result of their TBI
- Candidates who, in the opinion of the investigators, are unable to feel a sensory referred sensation from the stimulation or successfully complete the electrode placement and testing fNIRs
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 20 and 85 years old?
This trial is currently available in United States.
- University of Wisconsin - MadisonMadison, United StatesContact: Kip Ludwig, PhD (principal investigator)Taking people
About the trial
What the trial wants to find out
The purpose of this research is to demonstrate that mild stimulation of a nerve (trigeminal nerve) in the head can modulate blood flow in the brain. The modulated blood flow will restore the flow of cerebrospinal fluid (CSF) and this in turn can help improve waste clearance in the brain and prevent build up that may lead to disease.
The 2 groups in the trial
- Healthy ControlsExisting treatment, for comparison
Treatment: Functional near-infrared spectroscopy (fNIRS), V1 stimulation electrodes, Magnetic Resonance Imaging (MRI), and MAGNUS scanner
- Mild traumatic brain injury (mTBI)Existing treatment, for comparison
Participants with recent mTBI
Treatment: Functional near-infrared spectroscopy (fNIRS), V1 stimulation electrodes, and Magnetic Resonance Imaging (MRI)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07044596, who can take part
- Record updated
- 4 November 2026